Centers | ||
|
|
|
UCL TRO Drug Discovery Group | DRSC at Harvard Medical School | University of Pittsburgh Drug Discovery Institute |
UCL Translational Research Office(TRO) builds on an increasingly vibrant translational culture across the School of Life and Medical Sciences (SLMS) and the wider university community by providing integrated support for translational research,... |
Originally founded in 2003 to support RNAi screening in Drosophila cells, the DRSC has grown to include support for functional genomics screens in fly cells and in vivo, as well as for a number of bioinformatics analyses and visualization relevant to... |
UPDDI has a focus on the implementation of quantitative systems pharmacology in comprehensive programs in neurodegenerative diseases, liver diseases and metastatic breast cancer. We have a broad collaborative approach with other academic centers,... Read more |
Partnerships |
Events |
Jobs |
Yale to Partner with Gilead to Further Cancer ResearchYale and Gilead have entered into a multi-year research collaboration to develop new treatments against cancer. Gilead will provide $40million in funding for research and other infrastructure support for the initial four years. The agreement can... View all |
 I would like to extend an invitation to you to attend the 2020 Symposium hosted by the Drug... 10 March, 2021 The 8th edition of the conference intends again to bring together biophysicists and medicinal... 10 March, 2021 Chemical biology bridges academia and industry To promote research, education, and translational... 10 November, 2020 |
Research Scientist - Bristol-Myers Squibb
... 07 May, 2020 Learn More Michigan Biotech - CEO FibrosIX Inc ... 29 May, 2020 Learn More Drug Discovery Opportunities at D. E. Shaw Research
id: 21208 Computational Chemistry and Biology Opportunities at D. E. Shaw Research
id: 21210 |
